This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AptarGroup Reports Record Fourth Quarter Sales And Completes Record Year

AptarGroup, Inc. (NYSE:ATR) today reported record fourth quarter sales and record annual sales and earnings per share.

Fourth Quarter 2011 Summary
  • Sales up 3% to fourth quarter record of $545 million
  • Strong sales growth in Pharma and Food + Beverage segments
  • Beauty + Home sales and margins affected by softness in the U.S. and Europe
  • Effective tax rate rose to 36.2% compared to 30.4% a year ago due to increased French taxes of $1.7 million primarily related to a surtax enacted in December
  • Reported earnings per share reached $.57 compared to $.59 a year ago

FOURTH QUARTER RESULTS

For the quarter ended December 31, 2011, reported sales increased 3% to $544.5 million from $530.8 million a year ago. The effect of changes in currency exchange rates was insignificant.
Fourth Quarter Segment Sales Analysis

(Change Over Prior Year)
        Total
Beauty + Home   Pharma   Food + Beverage   AptarGroup
Product Sales (including tooling) --- 7 % 11 % 3 %
Currency Effects -1 % --- -1 % ---
Acquisitions 1 %   ---     ---     ---  
Total Reported Growth 0 %   7 %   10 %   3 %
 

Commenting on the quarter, Stephen J. Hagge, President and CEO, said, “The diversity of the markets and regions we serve once again proved that we can continue to grow in spite of softness in any one particular market or region. Consolidated sales grew on a reported and organic basis by 3%. As we anticipated, it was a challenging quarter for our Beauty + Home segment. We were going up against a strong fourth quarter of 2010 and certain customers remained cautious going into the end of the year particularly in the U.S. and Europe. However, strong results from Latin America and Asia allowed our Beauty + Home segment to achieve sales that were in-line with the prior year. Demand for our patient-friendly drug delivery devices from the prescription drug market drove our Pharma segment’s sales growth of 7%, and demand for innovative dispensing closures from the beverage market was the primary reason behind our Food + Beverage segment’s sales growth of 10%.”

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,102.38 -272.38 -1.66%
S&P 500 1,921.22 -29.91 -1.53%
NASDAQ 4,683.9190 -49.5780 -1.05%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs